The Central Drugs Standard Control Organisation (CDSCO) in coordination with State Drug Controllers of Madhya Pradesh has directed pharma firm Riemann Labs to halt manufacturing of its cough syrup that was linked to deaths of children in Cameroon. "In the case of Cameroon, a joint inspection was conducted by CDSCO, sub-zone Indore with SLA, Madhya Pradesh at M/s Riemann Labs, Indore and based on the findings the State Drugs Controller MP has directed the firm to stop the manufacturing activities," Minister of State (MoS) for Health Bharati Pravin Pawar said in a written reply in Rajya Sabha on Tuesday. The World Health Organization (WHO) had on July 19 issued an alert regarding cough syrup supplied in Cameroon stating an analysis has found that the product contained "unacceptable amounts of diethylene glycol as contaminants." The makers of Naturcold listed paracetamol, phenylephrine hydrochloride, and chlorpheniramine maleate as active ingredients, and a combination of these three i
Authorities have stepped up scrutiny of drugmakers after some cough syrups made in India were linked to deaths of dozens of children overseas
The move comes as Indian regulators step up inspections at drugmakers after cough syrups made in the country were linked to the deaths of dozens of children overseas, denting India's image as the "pha
India has suspended a drugmaker's manufacturing licence after the World Health Organization flagged contamination in its cough syrups found in the Mashall Islands and Micronesia in April
A devastating outbreak in Gambia claimed the lives of 60 kids. Tests conducted by WHO revealed that the cause was toxic industrial solvents found in cheap,over-the-counter syrups made by Maiden Pharma
Families of 20 of the children have already sued the two companies as well as Gambian authorities
The alert about Naturcold is the latest of several similar warnings issued in recent months about contaminated cough syrups sold worldwide
DCGI issues advisory to doctors and patients after risks of anaphylactic reactions
Regulator asks doctors to suggest an alternative to patients for treating their symptoms
Mandaviya said that after 137 firms were inspected, production has been stopped at 31 companies and the product licenses of 50 firms have been cancelled
Business Standard brings you the top headlines at this hour
From cough syrup to eyedrops to life-saving medications, quality lapses in one country can now endanger lives elsewhere as never before
Business Standard brings you the top headlines at this hour
The two sources said the syrup was made with industrial-grade PG, a toxic material widely used in liquid detergents, antifreeze, paints or coatings, and to enhance the effectiveness of pesticides
The WHO director-general issued a call to action in January to implore all member states to increase their surveillance and testing efforts because people are 'needlessly being put at risk'
Pharmaceutical exports from India have come under the scanner after sporadic incidents of contaminated or substandard medicines
Reports of contaminated medicines came out in 2022 in The Gambia, with subsequent reports in Indonesia, Uzbekistan, and Micronesia; all the products under the scanner are syrup-based
Catch all the live updates from across the globe here
The new rule highlights how governments are reassessing their reliance on India's $42 billion pharmaceutical industry since the contamination came to light last year
Catch all the latest live updates from across the globe here